Abstract
Purpose
To clarify the efficacy of transcatheter hepatic sub-subsegmental, subsegmental, and segmental arterial chemoembolization using lipiodol (subseg/seg lip-TACE) for hepatocellular carcinoma (HCC), long-term outcomes of patients who had been treated using subseg/seg lip-TACE alone were retrospectively examined.
Materials and Methods
Subjects comprised 199 patients with HCC (T1/2/≥3 = 30/108/61; Child–Pugh A/B/C = 115/52/32; Japan Integrated Staging [JIS] score ≤1/2/≥3 = 88/64/47) who underwent subseg/seg lip-TACE using lipiodol mixed with an anticancer drug followed by injection of gelatin sponge particles. Each patient was followed-up every 3 months, and repeat subseg/seg lip-TACE and/or conventional lip-TACE was performed in cases showing recurrence. One-, 3-, 5-, 7-, and 10-year cumulative survival rates were calculated. Subgroup analyses were performed by stratifying the population according to T-factor, Child–Pugh classification, and JIS score.
Results
Median duration of follow-up was 3.8 years (range 0.2 to 16.4). Median overall survival was 3.8 years. One-, 3-, 5-, 7- and 10-year survival rates were 91.5, 66.1, 38.8, 20.3, and 9.4% for all patients, and 95.5, 76.9, 51.9, 27.9 and 20.4% for patients with JIS ≤1, respectively. Significant survival differences were found across two subgroups of staging systems (T2 vs. T3≤ [P = 0.0012] and JIS score ≤1 vs. 2 [P = 0.0036]).
Conclusion
This study demonstrated that subseg/seg lip-TACE is a feasible treatment for obtaining prolonged survival in patients with localized HCC showing rich vasculature. Outcomes are influenced by both tumor stage and liver function, as seen in the best prolonged survival in patients with JIS score ≤1.
Similar content being viewed by others
References
Ohishi H, Uchida H, Yoshimura H et al (1985) Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 154:15–19
Ohishi H, Yoshimura H, Uchida H et al (1989) Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug the treatment for hepatocellular carcinoma. Cancer Chemother Pharmacol 23(Suppl):S33–S36
Nakamura H, Hashimoto T, Oi H et al (1989) Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170:783–786
Uchida H, Ohishi H, Matsuo N et al (1990) Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and gelfoam particle for hepatocellular carcinoma. Cardiovasc Intervent Radiol 13:140–145
Nakamura H, Hashimoto T, Oi H et al (1990) Treatment of hepatocellular carcinoma by segmental hepatic artery injection of adriamycin-in-oil emulsion with overflow to segmental portal veins. Acta Radiol 31:347–349
Nakao N, Uchida H, Kamino K et al (1992) Effectiveness of lipiodol in transcatheter arterial embolization of hepatocellular carcinoma. Cancer Chemother Pharmacol 31(Suppl):S72–S76
Uchida H, Matsuo N, Sakaguchi H et al (1993) Segmental embolotherapy for hepatic cancer: Key to success. Cardiovasc Intervent Radiol 16:67–71
Uchida H, Matsuo N, Nishimine K et al (1993) Transcatheter arterial embolization for hepatoma with lipiodol. Hepatic arterial and segmental use. Semin Intervent Radiol 10:19–26
Matsuo N, Uchida H, Nishimine K et al (1993) Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue. J Vasc Interv Radiol 4:543–549
Matsui O, Kadoya M, Yoshikawa J, Gabata T et al (1993) Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 188:79–83
Nishimine K, Uchida H, Matsuo N et al (1994) Segmental transarterial chemoembolization with lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol 33(Suppl):S60–S68
Nakao N, Uchida H, Kamino K et al (1994) Determination of the optimum dose level of lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysis. Cardiovasc Intervent Radiol 17:76–80
Matsuo N, Uchida H, Sakaguchi H et al (1997) Optimal lipiodol volume in transcatheter arterial chemoembolization for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings. Semin Oncol 24(Suppl 6):61–70
Nakamura H, Hashimoto T, Oi H, Sawada S (1998) Iodized oil in the portal vein after arterial embolization. Radiology 167:415–417
Takayasu K, Muramatsu Y, Maeda T et al (2001) Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol 176:681–688
Itsubo M, Koike K, Tsuno S et al (2002) Subsegmental transcatheter arterial embolization for small hepatocellular carcinoma. Hepatogastroenteroly 49:735–739
Higashihara H, Okazaki M (2002) Transcatheter arterial chemoembolization of hepatocellular carcinoma: a Japanese experience. Hepatogastroenteroly 49:72–78
Iwamoto S, Sanefuji H, Okuda K (2003) Angiographic subsegmentectomy for the treatment of patients with small hepatocellular carcinoma. Cancer 97:1051–1056
Miyayama S, Matsui O, Yamashiro M et al (2007) Ultraselective transcatheter arterial chemoembolization with a 2-F tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein iodized oil. J Vasc Interv Radiol 29:39–48
Iwamoto S, Yamaguchi T, Hongo O et al (2010) Excellent outcomes with angiographic subsegmentectomy in the treatment of typical hepatocellular carcinoma. Cancer 15:393–399
Miyagawa S, Kawasaki S (1998) Subsegmentectomy or segmentectomy in hepatocellular carcinoma. Hepatogastroenteroly 45:2–6
Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201–1209
Hasegawa K, Makuuchi M, Takayama T et al (2008) Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 49:589–594
Yamakado K, Nakatsuka A, Takaki H et al (2008) Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 247:260–266
Miyayama S, Matsui O, Taki K et al (2006) Extrahepatic blood supply to hepatocellular carcinomas: angiographic demonstration and transcatheter arterial chemoembolization. Cardiovasc Intervent Radiol 29:39–48
Iwazawa J, Ohue S, Mitani T et al (2009) Identifying feeding arteries during TACE of hepatic tumors: comparison of C-arm CT and digital subtraction angiography. AJR Am J Roentgenol 192:1057–1063
Miyayama S, Yamashiro M, Yoshie Y et al (2010) Hepatocellular carcinoma in the caudate lobe of the liver: variations of its feeding branches on arteriography. Jpn J Radiol 28:555–562
Takayasu K, Arii S, Ikai I et al (2006) Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131:461–469
Takayasu K, Arii S, Ikai I et al (2010) Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma. Propensity score analysis. AJR Am J Roentgenol 194:830–837
Satake M, Uchida H, Arai Y et al (2008) Transcatheter arterial chemoembolization (TACE) with lipiodol to treat hepatocellular carcinoma: survey results from the TACE study group of Japan. Cardiovasc Intervent Radiol 31:756–761
Liver Cancer Study Group of Japan (2008) The general rules for the clinical and pathological study of primary liver cancer (in Japanese), 5th edn. Kanehara, Tokyo, p 24
Kudo M, Chungg H, Haji S et al (2004) Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score as compared with CLIP score. Hepatology 40:1396–1405
Okusaka T, Okada S, Nakanishi T et al (2004) Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma. Invest New Drugs 22:169–176
Osuga K, Hori S, Hiraishi K et al (2008) Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres. Cardiovasc Intervent Radiol 31:1108–1116
Pelletier G, Roche A, Ink O et al (1990) A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11:181–184
Madden MV, Krige JE, Bailey S et al (1993) Randomized trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma. Gut 34:1598–1600
Groupe d’Etude et de Traitement du Carcinome Hepatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332:1256–1261
Bruix J, Llovet JM, Castells A et al (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27:1578–1583
Pelletier G, Ducreux M, Gay F et al (1998) Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicentre randomized trial. Groupe CHC. J Hepatol 29:129–134
Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–1171
Llovet JM, Real MI, Montana X et al (2002) Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359:1734–1739
Ernst O, Sergent G, Mizrahi D et al (1999) Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: comparison of planned periodic chemoembolization and chemoembolization based on tumor response. AJR Am J Roentgenol 172:59–64
Shim JH, Park JW, Choi JI et al (2009) Does postembolization fever after chemoembolization have prognostic significance for survival in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol 20:209–216
Sakaguchi H, Uchida H, Maeda M et al (1995) Combined transjugular intrahepatic portosystemic shunt and segmental lipiodol hepatic artery embolization for the treatment of esophagogastric varices and hepatocellular carcinoma in patients with cirrhosis: preliminary report. Cardiovasc Intervent Radiol 18(1):9–15
Miyayama S, Yamashiro M, Okuda M et al (2010) Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol 33:1168–1179
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takaki, S., Sakaguchi, H., Anai, H. et al. Long-Term Outcome of Transcatheter Subsegmental and Segmental Arterial Chemoemobolization Using Lipiodol for Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 35, 544–554 (2012). https://doi.org/10.1007/s00270-011-0224-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-011-0224-9